Modification of T2 phage infectivity toward Escherichia coli O157:H7 via using CRISPR/Cas9

FEMS Microbiology Letters
Fumiya HoshigaYasunori Tanji

Abstract

Phage therapy is getting considerable attention as a method for prophylaxis of food poisoning caused by Escherichia coli O157:H7, an important pathogen causing life-threatening bloody diarrhea. Despite previous studies have shown the feasibility of phage therapy to E. coli O157:H7, promising results have not been obtained in vivo yet. A major drawback of phage therapy is that bacteriophages have high specificity and cannot infect all the sub-strains of a particular pathogenic strain. To overcome this hurdle, we thought to establish a way to artificially expand the host-range of E. coli O157:H7-specific phages. To develop a proof-of-concept for this method, we focused on T2 phage, which cannot infect E. coli O157:H7 strains, and PP01 phage, which displays broad infectivity to them, and attempted to make T2 phage able to infect E. coli O157:H7 as efficiently as PP01. We report the trials of T2 genome editing using the CRISPR/Cas9 system and the modification of both long and short tail fibers of this phage based on comparison with PP01. The resultant recombinant showed the adsorption rate comparable to PP01. Thus, we provided the evidence that the short tail fiber of PP01 plays an important role in adsorption to E. coli O157:H7.

References

Nov 14, 1977·Molecular & General Genetics : MGG·G G WilsonN E Murray
Jan 1, 1965·Annual Review of Microbiology·W Arber
Dec 18, 2001·Journal of Molecular Biology·M J van RaaijS Miller
Jul 12, 2002·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Josep Casadesús, Richard D'Ari
Mar 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Eric S MillerWolfgang Rüger
Apr 1, 1955·Journal of Bacteriology·M LIEBE KELLENBERGER
Jun 9, 2004·Applied and Environmental Microbiology·G O'FlynnA Coffey
Dec 21, 2004·Journal of Biotechnology·Masatoshi YoichiYasunori Tanji
Oct 26, 2005·Journal of Bioscience and Bioengineering·Yasunori TanjiHajime Unno
Nov 7, 2006·Journal of Animal Science·C L Gyles
Sep 2, 2008·Genetics·Yongping Shao, Ing-Nang Wang
Oct 7, 2009·BMC Evolutionary Biology·Romain GalletIng-Nang Wang
May 20, 1940·The Journal of General Physiology·M Delbrück
Oct 30, 2010·Virology Journal·Vasiliy M PetrovJim D Karam
Nov 1, 2009·Microbial Biotechnology·R J Atterbury
Apr 22, 2011·Journal of Virology·Wei-Chao LiaoChuan-Hsiung Chang
Aug 27, 2011·Current Opinion in Microbiology·Timothy K Lu, Michael S Koeris
Feb 16, 2012·Bacteriophage·Catherine Loc-Carrillo, Stephen T Abedon
Aug 28, 2012·Journal of Virology·Andrew M KropinskiRoger P Johnson
Jan 31, 2013·Nature Biotechnology·Wenyan JiangLuciano A Marraffini
Jul 27, 2014·Nucleic Acids Research·Bruno Martel, Sylvain Moineau
Nov 10, 2015·Nature Reviews. Microbiology·George P C Salmond, Peter C Fineran
Mar 23, 2017·ACS Synthetic Biology·Marie-Laurence LemaySylvain Moineau
Jun 29, 2017·ACS Synthetic Biology·Pan TaoVenigalla Rao

❮ Previous
Next ❯

Citations

Feb 14, 2020·Viruses·Aurelija M GrigonyteAndrew Millard
Apr 22, 2021·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Małgorzata ŁobockaAndrzej Górski
Jun 15, 2021·EcoSal Plus·Nicholas Backes, Gregory J Phillips
Jul 30, 2021·Biochimica Et Biophysica Acta. General Subjects·Monika ŠimoliūnienėLidija Truncaitė

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.